Jérôme Viguier1, Jean-François Morère2, Xavier Pivot3, Chantal Touboul4, Christine Lhomel5, Sébastien Couraud6, Thibault de La Motte Rouge7, François Eisinger8,9. 1. CCDC 37, Hôpital Bretonneau, 2 Boulevard Tonnellé, 37044, Tours Cedex 9, France. jviguier@institutcancer.fr. 2. INSERM U1193 Département d'oncologie Médicale, Hôpital Paul Brousse, 12 avenue Paul Vaillant Couturier, 94804, Villejuif, France. 3. Centre de lutte contre le cancer Paul Strauss de Strasbourg, Hôpitaux Universitaires de Strasbourg, 3 Rue de la Porte de l'Hôpital, 67 065, Strasbourg Cedex, France. 4. Kantar Health, 3 Avenue Pierre Masse, 75014, Paris, France. 5. Roche SAS, 30 cours de l'île Seguin, 92650, Boulogne-Billancourt, France. 6. Service de Pneumologie Aiguë Spécialisée et Cancérologie Thoracique, Centre hospitalier Lyon Sud, 165 chemin du Grand Revoyet, 69495, Pierre Bénite Cedex, France. 7. Département d'oncologie médicale, Centre Eugène Marquis, Avenue de la Bataille Flandres-Dunkerque, 35000, Rennes, France. 8. INSERM, IRD, SESSTIM, Aix Marseille University, 23 rue Stanislas Torrents, 13006, Marseille, France. 9. Département d'Anticipation et de Suivi du Cancer DASC, Institut Paoli-Calmettes, 232 Boulevard Sainte Marguerite, BP 156, 13273, Marseille Cedex 9, France.
Abstract
BACKGROUND: The EDIFICE surveys have assessed cancer screening behavior in the French population since 2005. METHODS: The 2016 edition was conducted among a representative sample of 1501 individuals (age, 50-75 years). The current analysis focuses on breast, colorectal, prostate, lung, and cervical cancer screening. RESULTS: The rate of women (50 to 74 years) declaring having had at least one breast cancer screening test in their lifetime remained stable and high between 2005 and 2016. Compliance with recommended screening intervals improved between 2005 and 2011 from 75 to 83%, respectively, then decreased significantly to 75% in 2016 (P = 0.02). Uptake of at least one lifetime colorectal cancer screening test procedure declared (individuals aged 50-74 years) increase from 25% in 2005 to 59% in 2011, stabilized at 60% in 2014, then reached 64% in 2016. Opportunistic prostate cancer screening (men aged 50-75 years) rose between 2005 and 2008 from 36 to 49%, plateaued until 2014 then dropped to 42% in 2016. The proportion of women aged 50-65 declaring having undergone one cervical cancer screening test dropped significantly between 2014 and 2016 from 99 to 94% (P < 0.01). Lastly, 11% of our survey population in 2014 and 2016 (55-74 years) declared having already undergone lung cancer screening. CONCLUSION: Cancer screening behavior fluctuates in France, regardless of the context, i.e., organized programs or opportunistic screening. This observation highlights the need for constant analysis of population attitudes to optimize public awareness campaigns.
BACKGROUND: The EDIFICE surveys have assessed cancer screening behavior in the French population since 2005. METHODS: The 2016 edition was conducted among a representative sample of 1501 individuals (age, 50-75 years). The current analysis focuses on breast, colorectal, prostate, lung, and cervical cancer screening. RESULTS: The rate of women (50 to 74 years) declaring having had at least one breast cancer screening test in their lifetime remained stable and high between 2005 and 2016. Compliance with recommended screening intervals improved between 2005 and 2011 from 75 to 83%, respectively, then decreased significantly to 75% in 2016 (P = 0.02). Uptake of at least one lifetime colorectal cancer screening test procedure declared (individuals aged 50-74 years) increase from 25% in 2005 to 59% in 2011, stabilized at 60% in 2014, then reached 64% in 2016. Opportunistic prostate cancer screening (men aged 50-75 years) rose between 2005 and 2008 from 36 to 49%, plateaued until 2014 then dropped to 42% in 2016. The proportion of women aged 50-65 declaring having undergone one cervical cancer screening test dropped significantly between 2014 and 2016 from 99 to 94% (P < 0.01). Lastly, 11% of our survey population in 2014 and 2016 (55-74 years) declared having already undergone lung cancer screening. CONCLUSION:Cancer screening behavior fluctuates in France, regardless of the context, i.e., organized programs or opportunistic screening. This observation highlights the need for constant analysis of population attitudes to optimize public awareness campaigns.
Entities:
Keywords:
Cancer screening; Government program; Health behavior; Opinion pool
Authors: Fritz H Schröder; Jonas Hugosson; Monique J Roobol; Teuvo L J Tammela; Stefano Ciatto; Vera Nelen; Maciej Kwiatkowski; Marcos Lujan; Hans Lilja; Marco Zappa; Louis J Denis; Franz Recker; Alvaro Páez; Liisa Määttänen; Chris H Bangma; Gunnar Aus; Sigrid Carlsson; Arnauld Villers; Xavier Rebillard; Theodorus van der Kwast; Paula M Kujala; Bert G Blijenberg; Ulf-Hakan Stenman; Andreas Huber; Kimmo Taari; Matti Hakama; Sue M Moss; Harry J de Koning; Anssi Auvinen Journal: N Engl J Med Date: 2012-03-15 Impact factor: 91.245
Authors: John Concato; Carolyn K Wells; Ralph I Horwitz; David Penson; Graeme Fincke; Dan R Berlowitz; Gregory Froehlich; Dawna Blake; Martyn A Vickers; Gerald A Gehr; Nabil H Raheb; Gail Sullivan; Peter Peduzzi Journal: Arch Intern Med Date: 2006-01-09
Authors: J D Hardcastle; J O Chamberlain; M H Robinson; S M Moss; S S Amar; T W Balfour; P D James; C M Mangham Journal: Lancet Date: 1996-11-30 Impact factor: 79.321
Authors: Michael Pignone; Melissa Rich; Steven M Teutsch; Alfred O Berg; Kathleen N Lohr Journal: Ann Intern Med Date: 2002-07-16 Impact factor: 25.391
Authors: Robert Hodgson; Sylvia H Heywang-Köbrunner; Susan C Harvey; Mary Edwards; Javed Shaikh; Mick Arber; Julie Glanville Journal: Breast Date: 2016-03-25 Impact factor: 4.380